Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

MicroXpace


Genopole Campus 3,
4 Rue Pierre Fontaine,
F-91058 Évry-Courcouronnes

Email: vpalinauskas@microxpace.com

Dr Vaidas PALINAUSKAS: CEO
Dr Alejandro CABEZAS-CRUZ: CSO
  • Animal health
  • Deeptech
  • Probiotics
  • Pet animals
  • Poultry farming
  • Aquaculture
  • Alpha-Gal immunity
  • Disease resistance

Field of activity


Biotechnology for sustainable health solutions in animal farming (aquaculture, poultry, and pet animals) and combating parasitic diseases.

BACKGROUND
microXpace was established in March 2022 and specializes in microbiome-based biotechnologies to improve animal health. Its innovations focus on leveraging natural immune responses to reduce infectious disease burdens in aquaculture, poultry, and pet animals, promoting sustainable practices in food production and animal care.

DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY 

  • ChickGalX: A feed additive boosting anti-alpha-Gal antibodies in poultry, enhancing disease resistance.
  • AquaGalX: Similar alpha-Gal technology applied to aquaculture for pathogen resistance.
  • GiardiX: Probiotic treatment for giardiosis, using modified bile salts to combat the parasite Giardia intestinalis.
  • SalmonX: A feed-based solution that disrupts sea lice infestations in salmon farming.

These products utilize patented microbiome technologies to support health and reduce dependency on traditional medications.

ACHIEVEMENTS / COLLABORATIONS / HIGHLIGHTS

Collaborations

  • Partnered with Lallemand Animal Nutrition to develop alpha-Gal-based technologies.
  • Partnerships with INRAe (National Research Institute for Agriculture, Food and Environment, France); Centro Interdisciplinario para la Investigación Acuícola (INCAR, Chile); Nature Research Centre (NRC, Lithuania); University of Veterinary Medicine (vetmeduni, Austria)

Highlights

  • Transition to product development phase for alpha-Gal technology (March 2024).
  • Probiotic advancements targeting parasitic diseases.


COLLABORATIONS SOUGHT 

  • Research partnerships to expand microbial solutions into new markets.
  • Licensing agreements for technology in non-poultry and aquaculture industries.
  • Investors interested in scaling production and global distribution.
  • FURTHER INFORMATION

    3 patents
    8 staff members

    STRENGHTS

  • Groundbreaking solutions in probiotics and microbiome technology.
  • Focused expertise in disease resistance and pathogen control for aquaculture, poultry, and pet animals.
  • Collaboration with leading research institutions and organizations

  • INNOVATION ASSETS

  • Patented microbiome and alpha-Gal technology.
  • Solutions that reduce dependency on traditional medications, benefiting sustainability.
  • Recognition from international programs like Genopole Gene.iO.

  • OTHER FACTS

  • Operates at the intersection of biotechnology and sustainable food production.
  • Team includes distinguished professionals with expertise in parasitology, aquaculture innovation, and microbiome technologies.
SHARE
Companies directory

#Therapeutic products


In the same field

AGS Therapeutics - log

AGS Therapeutics

AGS Therapeutics is a biotech company pioneering the use of microalgae extracellular vesicles (MEVs) as a universal delivery system for innovative therapeutics, vaccines and gene therapies.

Discover
Synsight - Genopole's Company

Synsight

Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Discover
Pharming - Genopole's company - Logo 2021

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover
Genosafe - Genopole's Company

Genosafe

GenoSafe is a full contract research and consulting organization specialized in evaluating the quality, safety and efficacy of innovative biological products. Our goal is to enable our clients to move their products along clinical development rapidly and efficiently.

Discover
Généthon - Genopole's Laboratory

Généthon

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

Discover

Enterome

Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

Discover
Logo Ab Science - Genopole's company

AB Science

Research, development and commercialization of tyrosine kinase inhibitors as targeted therapy for pathologies with unmet medical needs.

Discover
View all >
With the support from
Région île de France